Link
- Argentinean Network of Women Living with HIV-AIDS
- Asia Pacific Network of People Living with HIV/AIDS
- bilaterals.org
- Cambodian People Living with HIV/AIDS Network (CPN+)
- Delhi Network of Positive People (DNP+)
- Essentialdrugs.org
- FACEBOOK PAGE: Stop the EU India Free Trade Agreement
- FTA Malaysia
- Health Action International – Asia Pacific
- Intellectual Property Watch
- Lawyers Collective HIV/AIDS Unit
- MSF Access Campaign
- National Association of People Living with HIV and AIDS in Nepal (NAPN)
- Public Citizen
- Stop Peru FTA
- Thai Network of People Living with HIV/Aids (TNP+)
- Third World Network
Take Action
Archives
-
Recent Posts
- The Cost of Price: Why and How to Get Beyond Intellectual Property Internalism
- WHA 65 adopted the resolution for way forward on CEWG report on R&D
- Corporations Win Big in Battle Against Investment Regulation
- US and EU Derailing Ten-year Process to Create Health Research & Development Convention
- MSF: Update on debates at World Health Assembly on a possible R&D convention, 23 May 2012
Categories
Monthly Archives: September 2011
Europe threatens to break off India free-trade talks
EU officials warn that negotiations will be broken off if an agreement is not reached by February 2012 AFP , Tuesday 27 Sep 2011 European governments are threatening to break off negotiations with India on a free-trade deal the EU … Continue reading
Posted in EU-India FTA, IP Rights
Leave a comment
Press Release: Novartis attempts to weaken Indian Patent Law that threatens to restrict access to live-saving medicines for millions in the developing world
Act Up -Paris Press Release This afternoon, Act Up-Paris protested in front of Novartis-France headquarters in Rueil Malmaison, a town near Paris. The activists blocked the entrance of the building and shut the gate. They unfurled a banner which said … Continue reading
Posted in patent evergreening, Sec 3 (d), TRIPS plus
Tagged Imatinib, Novartis, Supreme Court of India
Leave a comment
Generic Prescription Drugs saved $931 billion in United States in past 10 years, says US generic industry
Press Release by GPhA, 21 Sep 2011 New Study Finds Use of Generic Prescription Drugs Saved Consumers and the U.S. Health Care System $931 Billion Over Past 10 Years Savings Reached $158 Billion in 2010, Averaging $3 Billion Weekly WASHINGTON, … Continue reading
Posted in Drug Pricing, Generic drug, IP Rights
Tagged Generic drug, Generic Pharmaceutical Association, United States
Leave a comment
Natco Pharma’s compulsory license application for Cancer Drug- Sorafenib Tosylate
Recently, Natco Pharma, an Indian generic company had applied for Compulsory License (CL) to produce and sell the generic verson of Bayer’s patented cancer drug Sorafenib Tosylate (Brand name-Nexavar).This drug is used in the treatment for liver and kidney cancer. … Continue reading
Slideshow on Pharmacy to the Developing World May Shut Shop: IBSA News
IBSA News, Sep 19 2011 India’s generic drugs are a lifeline not only for millions of poor people in India, but also to developing countries in Africa, Asia and Latin America. So much so that India is known as the … Continue reading
Posted in EU-India FTA, Generic drug, HIV/Aids, TRIPS
Tagged Médecins Sans Frontières, World Trade Organization
Leave a comment
Comparative Analysis of the United States’ TPPA Intellectual Property Proposal and Malaysian Law
Public Citizen has done a comparative analysis of leaked Intellectual Property Chapter of US Trans-Pacific Partnership Agreement proposal with the Malaysian patent law to show the dangers of this agreement on access to medicines. The next round of TPP negotiations … Continue reading
USTR IPR Text Moves Away From ‘May 10′ Deal, Draws Fire From NGOs
Inside U.S. Trade – 09/16/2011 Posted: September 15, 2011 The U.S. proposal on pharmaceutical patent provisions in the Trans-Pacific Partnership (TPP), tabled this week during the eighth round of talks, moves away from patent provisions contained in the “May 10″ … Continue reading
Sharma writes to PM on pharma M&A concerns
Minister seeks ‘procedural filter’ on investments by foreign companies in Indian pharmaceutical firms Asit Ranjan Mishra The Livemint, 21 September 2011 India’s commerce and industry ministry is getting serious with its effort to have all foreign investment in Indian pharmaceutical … Continue reading
Posted in FDI, Mergers and Acquisitions
Tagged Anand Sharma, Foreign direct investment, Planning Commission
Leave a comment
Briefing Paper on EU-Andean FTA negotiations
The bilateral trade agreement negotiations between the EU and Peru & Colombia have concluded and implementation is now pending. Health Action International (HAI) Europe, has prepared a briefing paper providing an overview of the agreements’ history: the initial European demands on Intellectual Property; … Continue reading
